| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ANSGR
|
26.22 | 52.4B | 4.06 | 1.47 | — | — | — | 74 | 35 | 27.94 | +4.2% | 98 | 0.00 |
|
TURSG
|
6.00 | 60.0B | 3.07 | 1.21 | — | — | — | 73 | 47 | 8.21 | +23.5% | 100 | 0.23 |
|
AKGRT
|
6.08 | 9.8B | 4.08 | 1.25 | — | — | — | 70 | 27 | 6.18 | +1.0% | 88 | 0.03 |
|
RAYSG
|
150.00 | 24.5B | 6.38 | 2.61 | — | — | — | 58 | 25 | 97.12 | -22.6% | 97 | 0.00 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.